These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Clostridium difficile Infections in Children: Impact of the Diagnostic Method on Infection Rates. AlGhounaim M; Longtin Y; Gonzales M; Merckx J; Winters N; Quach C Infect Control Hosp Epidemiol; 2016 Sep; 37(9):1087-93. PubMed ID: 27263967 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of the Cepheid Xpert C. difficile/Epi and meridian bioscience illumigene C. difficile assays for detecting Clostridium difficile ribotype 033 strains. Androga GO; McGovern AM; Elliott B; Chang BJ; Perkins TT; Foster NF; Riley TV J Clin Microbiol; 2015 Mar; 53(3):973-5. PubMed ID: 25520452 [TBL] [Abstract][Full Text] [Related]
25. Detection of Senok AC; Aldosari KM; Alowaisheq RA; Abid OA; Alsuhaibani KA; Khan MA; Somily AM Saudi J Gastroenterol; 2017; 23(4):259-262. PubMed ID: 28721981 [TBL] [Abstract][Full Text] [Related]
26. Validation of a clinical prediction scale for hospital-onset Clostridium difficile infection. Chandra S; Thapa R; Marur S; Jani N J Clin Gastroenterol; 2014; 48(5):419-22. PubMed ID: 24172178 [TBL] [Abstract][Full Text] [Related]
27. Comparative performance study of six commercial molecular assays for rapid detection of toxigenic Clostridium difficile. Paitan Y; Miller-Roll T; Adler A Clin Microbiol Infect; 2017 Aug; 23(8):567-572. PubMed ID: 28223147 [TBL] [Abstract][Full Text] [Related]
28. Diagnosis of Clostridium difficile: real-time PCR detection of toxin genes in faecal samples is more sensitive compared to toxigenic culture. Jensen MB; Olsen KE; Nielsen XC; Hoegh AM; Dessau RB; Atlung T; Engberg J Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):727-36. PubMed ID: 25421216 [TBL] [Abstract][Full Text] [Related]
30. The evaluation of Clostridium difficile infection (CDI) in a community hospital. Daniel A; Rapose A J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221 [TBL] [Abstract][Full Text] [Related]
31. Trends and changes in Clostridium difficile diagnostic policies and their impact on the proportion of positive samples: a national survey. Adler A; Schwartzberg Y; Samra Z; Schwartz O; Carmeli Y; Schwaber MJ; Clin Microbiol Infect; 2014 Nov; 20(11):O904-10. PubMed ID: 24674056 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the diagnostic algorithm consisting of enzyme immunoassay for toxins and polymerase chain reaction, for the diagnosis of Clostridium difficile-associated diarrhoea. Lee JH; Park SJ; Lee YM; Lee CH; Cho JH Scand J Infect Dis; 2012 Dec; 44(12):969-72. PubMed ID: 22813084 [TBL] [Abstract][Full Text] [Related]
33. Improved detection of toxigenic Clostridium difficile using the Cepheid Xpert C difficile assay and impact on C difficile infection rates in a tertiary hospital: a double-edged sword. Williamson DA; Basu I; Freeman J; Swager T; Roberts SA Am J Infect Control; 2013 Mar; 41(3):270-2. PubMed ID: 22939418 [TBL] [Abstract][Full Text] [Related]
34. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting. Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169 [TBL] [Abstract][Full Text] [Related]
35. Polymerase chain reaction testing for Clostridium difficile. Catanzaro M; Cirone J Am J Infect Control; 2012 Aug; 40(6):580-1. PubMed ID: 22475569 [No Abstract] [Full Text] [Related]
36. Polymerase chain reaction testing for Clostridium difficile. Joob B; Wiwanitkit V Am J Infect Control; 2012 Aug; 40(6):580. PubMed ID: 22463792 [No Abstract] [Full Text] [Related]